[et_pb_section bb_built=”1″ admin_label=”section”][et_pb_row admin_label=”row” background_position=”top_left” background_repeat=”repeat” background_size=”initial”][et_pb_column type=”3_4″][et_pb_text admin_label=”Plenary Session & Keynote Speakers” background_layout=”light” text_orientation=”left” border_style=”solid” background_position=”top_left” background_repeat=”repeat” background_size=”initial” _builder_version=”3.0.65″]
Plenary Session & Keynote Speaker
A highlight of the ISPE Product Show, the plenary session and keynote bring together all attendees to hear from some of the most inspiring thought leaders who influence our field and our future.
2017 Plenary Session Keynote Speaker
President, Nitto Denko Avecia, Inc.
Oligonucleotide Therapeutics: The Promise and Reality from the Manufacturing Partners Prospective
The presentation will include a brief Company profile, and provide an overview about the oligonucleotide API market and relevant dynamics. The main portion of the talk will focus on applied ingredients and the different stages to building Avecia’s leading market position.
Detlef Rethage serves as President of Nitto Denko Avecia Inc., a leading manufacturer of oligonucleotide API’s (Active Pharmaceutical Ingredients), in Milford, MA, and Avecia’s subsidiary Nitto Avecia Pharma Services, Inc. in Irvine, CA, a contract service company offering sterile drug product manufacturing and analytical service.
Mr. Rethage served in various management positions for Degussa and its predecessors in Germany and Italy prior to leading Degussa’s Fine Chemical division in North America.
Mr. Rethage holds a M.S. in Engineering from the University Essen, Germany and a MBA equivalent degree from University Bochum, Germany.
[/et_pb_text][/et_pb_column][et_pb_column type=”1_4″][et_pb_sidebar orientation=”left” area=”sidebar-1″ background_layout=”light” /][/et_pb_column][/et_pb_row][/et_pb_section]